EUVIMEDEUVIMED entdecken
Crossref

Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”)

S H Slørdahl, E B Smeland, H Holte, M Grønn, S O Lie, M Seip

Medical and Pediatric Oncology · 1993-01 · 21 (4) · 254-258

DOI: 10.1002/mpo.2950210404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical and Pediatric Oncology, online erschienen am 20.07.2006. Verfasst von S H Slørdahl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Hospital, University of Oslo, Norway. Hauptthemen laut MEDLINE: Biomarkers, Tumor. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Among 16 patients with Down's syndrome (DS) and acute leukemia admitted to our department during a ten year period, 6 were diagnosed as acute megakaryoblastic leukemia (AMkL). The diagnosis was based on clinical and hematologic criteria, confirmed in three patients with the use of monoclonal antibodies (MoAb) specific for megakaryocytic antigens. In these three, and in a fourth patient, the leukemic blasts were positive for other myeloid, lymphoid and erythroid markers in MoAb testing. We suggest that AMkL in DS is a mixed lineage leukemia with blasts presenting a variety of cell surface antigens, indicating origin from an early progenitor cell with the capability of megakaryocytic differentiation. Of the 6 patients with AMkL, 4 treated with standard AML protocols are in complete continuing remission (CCR) with observation periods from 57+ to 148+ months. © 1993 Wiley‐Liss, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorAdolescentAdultAntibodies, MonoclonalAntigens, CDCytarabineDown SyndromeDoxorubicinFemaleHumansImmunophenotypingLeukemia, Megakaryoblastic, AcuteMaleMicroscopy, FluorescenceNeoplastic Stem Cells

Substanzen

Antibodies, MonoclonalAntigens, CDBiomarkers, TumorCytarabineDoxorubicin

Autor:innen und Institutionen

  • Department of Pediatrics, National Hospital, University of Oslo, Norway.

Zitieren

APA

Slørdahl, S. H., Smeland, E. B., Holte, H., Grønn, M., Lie, S. O., & Seip, M. (1993). Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”). Medical and Pediatric Oncology, 21(4), 254-258. https://doi.org/10.1002/mpo.2950210404

Vancouver

Slørdahl SH, Smeland EB, Holte H, Grønn M, Lie SO, Seip M. Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”). Medical and Pediatric Oncology. 1993;21(4):254-258. doi:10.1002/mpo.2950210404

BibTeX
@article{Slrdahl1993,
  author = {Slørdahl, S H and Smeland, E B and Holte, H and Grønn, M and Lie, S O and Seip, M},
  title = {Leukemic blasts with markers of four cell lineages in Down's syndrome (“megakaryoblastic leukemia”)},
  journal = {Medical and Pediatric Oncology},
  year = {1993},
  volume = {21},
  number = {4},
  pages = {254--258},
  doi = {10.1002/mpo.2950210404}
}
Kostenlos starten →